NovaBay Pharmaceuticals, Inc. EV/FCF

EV/FCF of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/FCF of NovaBay Pharmaceuticals, Inc. is -1.09 (as of December 31, 2021)
  • EV/FCF for the quarter ending September 30, 2022 was -0.38 (a -62.17% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -65.54%
  • Annual EV/FCF for 2021 was -1.09 (a -99.39% decrease from previous year)
  • Annual EV/FCF for 2020 was -178.62 (a 194.62% increase from previous year)
  • Annual EV/FCF for 2019 was -60.63 (a -24.96% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of NovaBay Pharmaceuticals, Inc.

Most recent EV/FCFof NBY including historical data for past 10 years.

Interactive Chart of EV/FCF of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.38 -1.0 -0.98
2021 -1.09 -3.17 -157.49 -247.96 -1.09
2020 -178.62 -214.26 -250.44 -104.65 -178.62
2019 -60.63 -56.86 -130.02 -82.01 -60.63
2018 -80.79 -155.92 -317.08 -407.32 -80.79
2017 -337.18 -625.74 -258.14 -227.89 -337.18
2016 -89.5 -96.81 -39.44 -15.8 -89.5
2015 -10.52 -41.03 -85.12 -86.88 -10.52
2014 -72.62 -94.9 -91.12 -133.08 -72.62
2013 -124.37 -194.95 -189.33 -256.04 -124.37
2012 -172.09 -321.75 -335.08 -218.62 -172.09
2011 -363.59 -363.59

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology